Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-338637

Chief Development Officer sold 3,700 shares at $113.12 ($418,562)

  • Chief Development Officer acquired 3,700 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Guyer William Chief Development Officer 2026-08-04 Option exercise 10b5-1 +3,700 $21.65 $80,105 7,685 D: show line 1 in the form
Guyer William Chief Development Officer 2026-08-04 Sale 10b5-1 −3,700 $113.12 $418,562 3,985 D: show line 2 in the form
Open-market sales · 3,700 sh · avg $113.12 · $418,562

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Guyer William Chief Development Officer 2026-08-04 Option exercise · Stock Option (right to buy) 10b5-1 −3,700 126,300 D: show line 3 in the form
Loading xslF345X06/ownership.xml…